|
|||||
|
|
Association of adverse events and associated cost with efficacy for approved relapsed and/or refractory multiple myeloma regimens: A Bayesian network meta-analysis of phase 3 randomized controlled trials |
|
| Authors: | Binod Dhakal MD MS Ravi K. Narra MD MS Smith Giri MD MHS Aniko Szabo PhD Timothy L. Smunt DBA Sanjoy Ghose PhD Lakshmi Kant Pathak MD Madan Aryal MD Mehdi Hamadani MD Saurabh Chhabra MD MS Siegfried Janz MD Anita D’Souza MD Parameswaran N. Hari MD MS MRCP |
| Affiliation: | 1. Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin;2. Division of Hematology/Oncology, Yale University, New Haven, Connecticut;3. Division of Biostatistics, Medical College of Wisconsin, Milwaukee, Wisconsin;4. Sheldon B. Lubar School of Business, University of Wisconsin Milwaukee, Milwaukee, Wisconsin;5. Division of Nephrology, University of Illinois Chicago, Chicago, Illinois;6. Division of Hematology/Oncology, Roswell Park, Buffalo, New York |
| Abstract: | |
| Keywords: | adverse events relapsed and/or refractory multiple myeloma total cost per cycle |